ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU)
CUSIP: 005083100
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 23,165,208
- Total 13F shares
- 10,401,592
- Share change
- +285,456
- Total reported value
- $70,445,498
- Price per share
- $6.77
- Number of holders
- 25
- Value change
- +$1,934,199
- Number of buys
- 19
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 005083100?
CUSIP 005083100 identifies ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 005083100:
Top shareholders of ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BIOS Capital Management, LP |
13F
|
Company |
43%
|
9,893,651
|
$78,753,462 | — | 31 Dec 2024 | |
| Voss Capital, LP |
13F
|
Company |
0.24%
|
55,246
|
$439,758 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
27,893
|
$222,028 | — | 31 Dec 2024 | |
| NORTHWESTERN UNIVERSITY |
13F
|
Company |
0.12%
|
27,778
|
$221,111 | — | 31 Dec 2024 | |
| MERCER GLOBAL ADVISORS INC /ADV |
13F
|
Company |
0.07%
|
16,344
|
$130,098 | — | 31 Dec 2024 | |
| Sigma Planning Corp |
13F
|
Company |
0.07%
|
16,075
|
$127,957 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.06%
|
14,296
|
$113,796 | — | 31 Dec 2024 | |
| KG&L Capital Management,LLC |
13F
|
Company |
0.05%
|
12,000
|
$95,520 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
11,253
|
$89,574 | — | 31 Dec 2024 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.05%
|
10,583
|
$84,241 | — | 31 Dec 2024 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
10,465
|
$83,301 | — | 31 Dec 2024 | |
| Freestone Capital Holdings, LLC |
13F
|
Company |
0.04%
|
10,000
|
$79,600 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.03%
|
7,745
|
$61,651 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,934
|
$15,395 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
542
|
$4,314 | — | 31 Dec 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
302
|
$2,000 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
24
|
$191 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3
|
$24 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
2
|
$16 | — | 31 Dec 2024 | |
| Bios Clinical Opportunity Fund, LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
231,377
|
— | — | 12 Aug 2024 | |
| Bios 2024 Co-Invest, LP |
3/4/5
|
Director, Member of 10% Group |
—
class O/S missing
|
125,000
|
— | — | 14 Aug 2024 |
Institutional Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) as of Q1 2025
As of 31 Mar 2025,
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,401,592 shares.
The largest 10 holders included
BIOS Capital Management, LP, Voss Capital, LP, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, NORTHWESTERN UNIVERSITY, Sigma Planning Corp, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, and ROYAL BANK OF CANADA.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
19
Q1 2025 holders
25
Holder diff
6
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.